Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Braskem S.A. (BAK) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Braskem S.A. (BAK) - free report >>
Image: Bigstock
New Strong Sell Stocks for July 28th
Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today:
Acer Therapeutics (ACER - Free Report) is a pharmaceutical company that develops therapies for the treatment of ultra-rare diseases with critical unmet medical needs.The Zacks Consensus Estimate for its current year earnings has been revised 46.4% downward over the last 60 days.
Braskem (BAK - Free Report) is the largest petrochemical operations company in Latin America and among the five largest private companies in Brazil. The Zacks Consensus Estimate for its current year earnings has been revised 42.4% downward over the last 60 days.
Central Japan Railway Co. (CJPRY - Free Report) is engaged in the railway, transportation and related businesses in Japan. The Zacks Consensus Estimate for its current year earnings has been revised almost 11.1% downward over the last 60 days.
View the entire Zacks Rank #5 List.